|
|
 Previous Article | Table of Contents | Next Article 
RAPID COMMUNICATION
A Metalloproteinase Inhibitor Prevents Lethal Acute Graft-Versus-Host Disease in Mice
Koichi Hattori,
Takao Hirano,
Chifuyu Ushiyama,
Hiroaki Miyajima,
Norifumi Yamakawa,
Tomohiko Ebata,
Yukihisa Wada,
Shoji Ikeda,
Kohichiro Yoshino,
Masatoshi Tateno,
Kazuo Oshimi,
Nobuhiko Kayagaki,
Hideo Yagita, and
Ko Okumura
From the Division of Hematology and the Division of Rheumatology, the Department of Internal Medicine, the Division of Pathobiology, and the Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan; the New Drug Discovery Research Laboratory, Kanebo Ltd, Osaka, Japan; and the Department of Pathology, Sapporo City General Hospital, Sapporo, Japan.
Tumor necrosis factor (TNF ) and Fas ligand (FasL) have been implicated in the pathogenesis of graft-versus-host disease (GVHD), which is a major complication after allogeneic bone marrow transplantation. We examined here the ameliorating effect of a metalloproteinase inhibitor (KB-R7785) that inhibits TNF- and FasL release in a lethal acute GVHD model in mice. Administration of KB-R7785 into (BALB/c × C57BL/6) F1 that received C57BL/6 spleen cells markedly reduced the mortality and weight loss in association with minimal signs of GVHD pathology in the liver, intestine, and hematopoietic tissues. The ameliorating effect of KB-R7785 was superior to that of anti-TNF- antibody. Our results suggest that KB-R7785 could be a potent therapeutic agent for GVHD.
Blood, Vol. 90 No. 2 (July 15), 1997:
pp. 542-548
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. S. Mohamood, M. L. Guler, Z. Xiao, D. Zheng, A. Hess, Y. Wang, H. Yagita, J. P. Schneck, and A. R. A. Hamad
Protection from Autoimmune Diabetes and T-Cell Lymphoproliferation Induced by FasL Mutation Are Differentially Regulated and Can Be Uncoupled Pharmacologically
Am. J. Pathol.,
July 1, 2007;
171(1):
97 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Liu, J. G. Heuer, S. Na, E. Galbreath, T. Zhang, D. D. Yang, A. Glasebrook, and H. Y. Song
Accelerated Onset and Increased Severity of Acute Graft-Versus-Host Disease Following Adoptive Transfer of DR6-Deficient T Cells
J. Immunol.,
October 1, 2002;
169(7):
3993 - 3998.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nakayama, M. Nagata, H. Yasuda, K. Arisawa, R. Kotani, K. Yamada, S. A. Chowdhury, S. Chakrabarty, Z. Z. Jin, H. Yagita, et al.
Fas/Fas Ligand Interactions Play an Essential Role in the Initiation of Murine Autoimmune Diabetes
Diabetes,
May 1, 2002;
51(5):
1391 - 1397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Okamoto, S. Kato, K. Oizumi, M. Kinoshita, Y. Inoue, K. Hoshino, S. Akira, A. N. J. Mckenzie, H. A. Young, and T. Hoshino
Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia
Blood,
February 15, 2002;
99(4):
1289 - 1298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ishimaru, K. Yanagi, K. Ogawa, T. Suda, I. Saito, and Y. Hayashi
Possible Role of Organ-Specific Autoantigen for Fas Ligand-Mediated Activation-Induced Cell Death in Murine Sjogren's Syndrome
J. Immunol.,
November 15, 2001;
167(10):
6031 - 6037.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Schmaltz, O. Alpdogan, K. J. Horndasch, S. J. Muriglan, B. J. Kappel, T. Teshima, J. L. M. Ferrara, S. J. Burakoff, and M. R. M. van den Brink
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
Blood,
May 1, 2001;
97(9):
2886 - 2895.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Lu, S. Sakamaki, H. Kuroda, T. Kusakabe, Y. Konuma, T. Akiyama, A. Fujimi, N. Takemoto, K. Nishiie, T. Matsunaga, et al.
Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603
Blood,
February 15, 2001;
97(4):
1123 - 1130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Dri, C. Gasparini, R. Menegazzi, R. Cramer, L. Alberi, G. Presani, S. Garbisa, and P. Patriarca
TNF-Induced Shedding of TNF Receptors in Human Polymorphonuclear Leukocytes: Role of the 55-kDa TNF Receptor and Involvement of a Membrane-Bound and Non-Matrix Metalloproteinase
J. Immunol.,
August 15, 2000;
165(4):
2165 - 2172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Miura, D. Mizuki, S. Sasaki, S. Hasegawa, H. Sashinami, and A. Nakane
Host Resistance to Listeria monocytogenes Infection Is Enhanced but Resistance to Staphylococcus aureus Infection Is Reduced in Acute Graft-versus-Host Disease in Mice
Infect. Immun.,
July 1, 2000;
68(7):
4340 - 4343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kanda, M. Kuzuya, M. A. Ramos, T. Koike, K. Yoshino, S. Ikeda, and A. Iguchi
Matrix Metalloproteinase and {alpha}v{beta}3 Integrin-Dependent Vascular Smooth Muscle Cell Invasion Through a Type I Collagen Lattice
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2000;
20(4):
998 - 1005.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Tsukada, H. Akiba, T. Kobata, Y. Aizawa, H. Yagita, and K. Okumura
Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation
Blood,
April 1, 2000;
95(7):
2434 - 2439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E.P. Dekkers, F. N. Lauw, T. ten Hove, A. A. te Velde, P. Lumley, D. Becherer, S. J.H. van Deventer, and T. van der Poll
The Effect of a Metalloproteinase Inhibitor (GI5402) on Tumor Necrosis Factor-alpha (TNF-alpha ) and TNF-alpha Receptors During Human Endotoxemia
Blood,
October 1, 1999;
94(7):
2252 - 2258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ries, F. Loher, C. Zang, M. G. Ismair, and P. E. Petrides
Matrix Metalloproteinase Production by Bone Marrow Mononuclear Cells from Normal Individuals and Patients with Acute and Chronic Myeloid Leukemia or Myelodysplastic Syndromes
Clin. Cancer Res.,
May 1, 1999;
5(5):
1115 - 1124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Tsukada, T. Kobata, Y. Aizawa, H. Yagita, and K. Okumura
Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation
Blood,
April 15, 1999;
93(8):
2738 - 2747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hattori, T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi, N. Kayagaki, H. Yagita, and K. Okumura
Differential Effects of Anti-Fas Ligand and Anti-Tumor Necrosis Factor alpha Antibodies on Acute Graft-Versus-Host Disease Pathologies
Blood,
June 1, 1998;
91(11):
4051 - 4055.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
